Genetic Studies of POAG in Hispanic Americans
About the Research Project
Program
Award Type
Standard
Award Amount
$69,731
Active Dates
April 01, 2003 - September 30, 2005
Grant ID
G2003016
Summary
The objective of this research is to examine Hispanic individuals and eventually, families with Primary Open-Angle Glaucoma (POAG) who live in the regions around Tucson, Arizona for a genetic mutation that leads to glaucoma. Dr. Allingham has hypothesized that optineurin (OPTN), a gene known to be associated with normal-tension POAG, may play an important role in the development of glaucoma in Hispanics. In order to explore this hypothesis, Dr. Allingham’s team is evaluating one hundred unrelated individuals with POAG, and an equal number of age- and sex-matched control subjects. Blood samples will be drawn for DNA analysis and genetic studies, and these samples will then be analyzed at the Center for Genetics at Duke University. The first objective of this proposal is to help elucidate this potential causative factor in a Hispanic population. The long-term goal will be to collect multiplex families (families containing multiple affected members) for genetic linkage analysis. This will help determine the role of mutations in known genes that cause POAG in this population, screen new genes as they are discovered, and contribute to the process of discovering currently unknown genes that affect Hispanic Americans.
Related Grants
National Glaucoma Research
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine
National Glaucoma Research
Measuring the Effects of Visual Stimuli on Retinal Blood Vessels and Flow
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Stuart Gardiner, PhD
Current Organization
Good Samaritan Foundation, Legacy Health System
Measuring the Effects of Visual Stimuli on Retinal Blood Vessels and Flow
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Stuart Gardiner, PhD
Current Organization
Good Samaritan Foundation, Legacy Health System
National Glaucoma Research
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet